Karyopharm Therapeutics Inc. (KPTI) dropped 11.86 percent, declining $0.68 to $5.09 on Wednesday, after the company announced a series of financing and capital structure transactions expected to provide $100 million in funding and extend its cash runway into the second quarter of 2026.
The stock is currently trading at $5.03, compared with a previous close of $5.77 on the Nasdaq. Shares opened at $4.65 and have traded between $4.51 and $5.15 so far today, with trading volume rising to 2.1 million shares, well above the average of 173,000.
Over the past 52 weeks, Karyopharm shares have ranged between $3.51 and $16.95.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.